Arid
DOI10.1186/s40425-019-0712-z
High numbers of activated helper T cells are associated with better clinical outcome in early stage vulvar cancer, irrespective of HPV or p53 status
Kortekaas, Kim E.1,3; Santegoets, Saskia J.3; Abdulrahman, Ziena3; van Ham, Vanessa J.3; van der Tol, Marij2; Ehsan, Ilina3; van Doom, Helena C.4; Bosse, Tjalling5; van Poelgeest, Mariette I. E.2; van der Burg, Sjoerd H.3
通讯作者van der Burg, Sjoerd H.
来源期刊JOURNAL FOR IMMUNOTHERAPY OF CANCER
ISSN2051-1426
出版年2019
卷号7期号:1
英文摘要Background Vulvar squamous cell carcinoma (VSCC) has been suggested to consist of three subtypes; HPV-positive, HPV-negative mutated TP53 or HPV-negative TP53 wildtype, with different clinical courses. To analyze the immune infiltrate in these molecular subtypes and its impact on clinical outcome, an in-depth study of the tumor immune microenvironment was performed. Methods Sixty-five patients with invasive VSCC matched for age, FIGO stage and treatment modality, were grouped according to the presence of HPV and p53 protein expression status. Archived tissues were analyzed for intraepithelial and stromal expression of CD3, CD8, Foxp3, PD-1, and pan-keratin in randomly selected areas using immunofluorescence. Additional phenotyping of T cells was performed ex-vivo on VSCC (n = 14) and blood samples by flow cytometry. Healthy vulvar samples and blood served as controls. Results Based on T-cell infiltration patterns about half of the VSCC were classified as inflamed or altered-excluded while one-third was immune-deserted. High intraepithelial helper T cell infiltration was observed in 78% of the HPV-induced VSCC, 60% of the HPVnegVSCC/p53wildtype and 40% of the HPVnegVSCC with abnormal p53 expression. A high intraepithelial infiltration with activated (CD3(+)PD-1(+)), specifically helper T cells (CD3(+)CD8(-)Foxp3(-)), was associated with a longer recurrence-free period and overall survival, irrespective of HPV and p53 status. Flow cytometry confirmed the tumor-specific presence of activated (CD4(+)PD-1(++)CD161(-)CD38(+)HLA-DR+ and CD8(+)CD103(+)CD161(-)NKG2A(+/-)PD1(++)CD38(++)HLA-DR+) effector memory T cells. Conclusion This is the first study demonstrating an association between intraepithelial T cells and clinical outcome in VSCC. Our data suggest that abnormal p53 expressing VSCCs mostly are cold tumors whereas HPV-driven VSCCs are strongly T-cell infiltrated.
英文关键词Vulvar cancer Tumor microenvironment Immunotherapy T cells PD-1
类型Article
语种英语
国家Netherlands
开放获取类型Green Published, gold
收录类别SCI-E
WOS记录号WOS:000483765300001
WOS关键词INTRAEPITHELIAL NEOPLASIA ; PROGNOSTIC-SIGNIFICANCE ; CARCINOMA ; EXPRESSION ; MICROENVIRONMENT ; IMMUNOTHERAPY ; INFILTRATION ; RECURRENCE ; IMIQUIMOD ; CONSENSUS
WOS类目Oncology ; Immunology
WOS研究方向Oncology ; Immunology
资源类型期刊论文
条目标识符http://119.78.100.177/qdio/handle/2XILL650/216586
作者单位1.Leiden Univ, Med Ctr, Oncode Inst, Dept Gynecol, POB 9600, NL-2300 RC Leiden, Netherlands;
2.Leiden Univ, Med Ctr, Dept Gynecol, POB 9600, NL-2300 RC Leiden, Netherlands;
3.Leiden Univ, Med Ctr, Oncode Inst, Dept Med Oncol, POB 9600, NL-2300 RC Leiden, Netherlands;
4.Univ Med Ctr Rotterdam, Erasmus MC Canc Inst, Dept Gynecol Oncol, POB 2040, NL-2300 CA Rotterdam, Netherlands;
5.Leiden Univ, Med Ctr, Dept Pathol, POB 9600, NL-2300 RC Leiden, Netherlands
推荐引用方式
GB/T 7714
Kortekaas, Kim E.,Santegoets, Saskia J.,Abdulrahman, Ziena,et al. High numbers of activated helper T cells are associated with better clinical outcome in early stage vulvar cancer, irrespective of HPV or p53 status[J],2019,7(1).
APA Kortekaas, Kim E..,Santegoets, Saskia J..,Abdulrahman, Ziena.,van Ham, Vanessa J..,van der Tol, Marij.,...&van der Burg, Sjoerd H..(2019).High numbers of activated helper T cells are associated with better clinical outcome in early stage vulvar cancer, irrespective of HPV or p53 status.JOURNAL FOR IMMUNOTHERAPY OF CANCER,7(1).
MLA Kortekaas, Kim E.,et al."High numbers of activated helper T cells are associated with better clinical outcome in early stage vulvar cancer, irrespective of HPV or p53 status".JOURNAL FOR IMMUNOTHERAPY OF CANCER 7.1(2019).
条目包含的文件
条目无相关文件。
个性服务
推荐该条目
保存到收藏夹
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[Kortekaas, Kim E.]的文章
[Santegoets, Saskia J.]的文章
[Abdulrahman, Ziena]的文章
百度学术
百度学术中相似的文章
[Kortekaas, Kim E.]的文章
[Santegoets, Saskia J.]的文章
[Abdulrahman, Ziena]的文章
必应学术
必应学术中相似的文章
[Kortekaas, Kim E.]的文章
[Santegoets, Saskia J.]的文章
[Abdulrahman, Ziena]的文章
相关权益政策
暂无数据
收藏/分享

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。